The US Food and Drug Administration (FDA) has notified CSL of ''deviations'' in good manufacturing practice in that CSL had failed to investigate thoroughly an ''unexplained discrepancy'' in the formation of dark particles in its Alfuria flu vaccine, produced for the US market. The FDA report, based on a survey of the Melbourne plant undertaken in April, came just as the first of 100 cases of convulsions among infants vaccinated with CSL's Fluvax flu product were occurring.
Seeded on Sat Jul 10, 2010 1:44 PM EDT
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
adulterated vaccines not a concern for big pharma.....big concern for people who still have a brain...or should I say those who boldly exercise critical thinking instead of F-ing others for the dollar....SICK!
- 1 vote
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



